Ko K - Search Results

1

Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.

Ko K, Wang J, Perper S, Jiang Y, Yanez D, Kaverina N, Ai J, Liarski VM, Chang A, Peng Y, Lan L, Westmoreland S, Olson L, Giger ML, Chun Wang L, Clark MR. Ko K, et al. Arthritis Rheumatol. 2016 Nov;68(11):2740-2751. doi: 10.1002/art.39744. Arthritis Rheumatol. 2016. PMID: 27159593 Free PMC article.

2

The emerging role of the inflammasome in kidney diseases.

Chang A, Ko K, Clark MR. Chang A, et al. Among authors: ko k. Curr Opin Nephrol Hypertens. 2014 May;23(3):204-10. doi: 10.1097/01.mnh.0000444814.49755.90. Curr Opin Nephrol Hypertens. 2014. PMID: 24685591 Free PMC article. Review.

3

Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis.

Kinloch AJ, Chang A, Ko K, Henry Dunand CJ, Henderson S, Maienschein-Cline M, Kaverina N, Rovin BH, Salgado Ferrer M, Wolfgeher D, Liarski V, Haddon DJ, Utz PJ, Wilson PC, Clark MR. Kinloch AJ, et al. Among authors: ko k. Arthritis Rheumatol. 2014 Dec;66(12):3359-70. doi: 10.1002/art.38888. Arthritis Rheumatol. 2014. PMID: 25306868 Free PMC article.

4

Cellular aspects of the pathogenesis of lupus nephritis.

Chang A, Clark MR, Ko K. Chang A, et al. Among authors: ko k. Curr Opin Rheumatol. 2021 Mar 1;33(2):197-204. doi: 10.1097/BOR.0000000000000777. Curr Opin Rheumatol. 2021. PMID: 33394604 Free PMC article. Review.

5

Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection.

Asano Y, Daccache J, Jain D, Ko K, Kinloch A, Veselits M, Wolfgeher D, Chang A, Josephson M, Cunningham P, Tambur A, Khan AA, Pillai S, Chong AS, Clark MR. Asano Y, et al. Among authors: ko k. Nat Commun. 2021 Jul 16;12(1):4372. doi: 10.1038/s41467-021-24615-6. Nat Commun. 2021. PMID: 34272370 Free PMC article.

6

Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis.

Abraham R, Durkee MS, Ai J, Veselits M, Casella G, Asano Y, Chang A, Ko K, Oshinsky C, Peninger E, Giger ML, Clark MR. Abraham R, et al. Among authors: ko k. J Clin Invest. 2022 Jul 1;132(13):e155350. doi: 10.1172/JCI155350. J Clin Invest. 2022. PMID: 35608910 Free PMC article.

7

Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis.

Kinloch AJ, Cascino MD, Dai J, Bermea RS, Ko K, Vesselits M, Dragone LL, Mor Vaknin N, Legendre M, Markovitz DM, Okoreeh MK, Townsend MJ, Clark MR. Kinloch AJ, et al. Among authors: ko k. Lupus. 2020 May;29(6):569-577. doi: 10.1177/0961203320913606. Epub 2020 Mar 26. Lupus. 2020. PMID: 32216516 Free PMC article.

8

Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus.

Ko K, Franek BS, Marion M, Kaufman KM, Langefeld CD, Harley JB, Niewold TB. Ko K, et al. J Rheumatol. 2012 Jun;39(6):1238-40. doi: 10.3899/jrheum.111467. Epub 2012 Apr 15. J Rheumatol. 2012. PMID: 22505704 Free PMC article.

9

Refractory dermatomyositis responsive to anifrolumab.

Ang PS, Ezenwa E, Ko K, Hoffman MD. Ang PS, et al. Among authors: ko k. JAAD Case Rep. 2023 Nov 7;43:27-29. doi: 10.1016/j.jdcr.2023.10.023. eCollection 2024 Jan. JAAD Case Rep. 2023. PMID: 38162409 Free PMC article. No abstract available.

10

The impact of education and clinical decision support on the quality of positive antinuclear antibody referrals.

Patel V, Ko K, Dua AB. Patel V, et al. Among authors: ko k. Clin Rheumatol. 2021 Jul;40(7):2921-2925. doi: 10.1007/s10067-021-05594-x. Epub 2021 Jan 20. Clin Rheumatol. 2021. PMID: 33474658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,857 results

Search Page

Filters